Stockreport

ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs [Yahoo! Finance]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF exclusive license agreement with Biosion for global rights (excluding Greater China) to two of the latter's pipeline candidates, BSI-045B and BSI-502. Biosion's BSI-04 [Read more]